Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Aerovate Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AVTE.
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Other companies in Aerovate Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
Aerovate Therapeutics has a consensus price target of $11.75.
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.74 last updated April 14, 2025 at 7:12 PM EDT.
There are no upcoming dividends for Aerovate Therapeutics.
Aerovate Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Aerovate Therapeutics.
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.